Andrew Booth - 20 Dec 2022 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: Chief Financial Officer
Signature: Tryn Stimart, attorney-in-fact
Issuer symbol: ABCL
Transactions as of: 20 Dec 2022
Net transactions value: +$9,500
Form type: 4
Filing time: 22 Dec 2022, 13:31:23 UTC
Previous filing: 05 Dec 2022
Next filing: 26 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABCL	Common Shares	Options Exercise	$9,500	+50,000	+36%	$0.1900^*	188,500	20 Dec 2022	Direct
transaction	ABCL	Common shares	Gift	$0	-50,000	-27%	$0.000000	138,500	20 Dec 2022	Direct	F1
holding	ABCL	Common shares						130,959	20 Dec 2022	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABCL	Share option (right to buy)	Options Exercise	$0	-50,000	-0.85%	$0.000000	5,820,481	20 Dec 2022	Common shares	50,000	$0.1900	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction represents a charitable donation of 50,000 common shares the reporting person donated on December 20, 2022.
F2	The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.